Immutep Limited Stock Return On Equity
PRRUF Stock | USD 0.26 0.00 0.00% |
Immutep Limited fundamentals help investors to digest information that contributes to Immutep's financial success or failures. It also enables traders to predict the movement of Immutep Pink Sheet. The fundamental analysis module provides a way to measure Immutep's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immutep pink sheet.
Immutep |
Immutep Limited Company Return On Equity Analysis
Immutep's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Immutep Return On Equity | -0.38 |
Most of Immutep's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Immutep Limited has a Return On Equity of -0.3849. This is 98.39% lower than that of the Healthcare sector and 98.94% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 24.16% higher than that of the company.
Immutep Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immutep's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics of similar companies.Immutep is currently under evaluation in return on equity category among related companies.
Immutep Fundamentals
Return On Equity | -0.38 | |||
Return On Asset | -0.23 | |||
Operating Margin | (7.18) % | |||
Current Valuation | 142.99 M | |||
Shares Outstanding | 879.09 M | |||
Shares Owned By Insiders | 4.61 % | |||
Shares Owned By Institutions | 24.04 % | |||
Price To Earning | (2.50) X | |||
Price To Book | 2.81 X | |||
Price To Sales | 33.12 X | |||
Revenue | 247.66 K | |||
Gross Profit | (26.63 M) | |||
EBITDA | (43.69 M) | |||
Net Income | (32.21 M) | |||
Cash And Equivalents | 80 M | |||
Cash Per Share | 0.09 X | |||
Total Debt | 2.11 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 14.16 X | |||
Book Value Per Share | 0.11 X | |||
Cash Flow From Operations | (30.23 M) | |||
Earnings Per Share | (0.02) X | |||
Number Of Employees | 17 | |||
Beta | 1.95 | |||
Market Capitalization | 171.77 M | |||
Total Asset | 148.52 M | |||
Retained Earnings | (222 M) | |||
Working Capital | 21 M | |||
Current Asset | 22 M | |||
Current Liabilities | 1000 K | |||
Z Score | 47.2 | |||
Net Asset | 148.52 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Immutep Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Transaction History View history of all your transactions and understand their impact on performance |